FDA Investigator

Mary L Schuckmann

Latest inspection on record: Saint Louis, United States, March 2026 · records back to 2021

Human DrugsMedical Devices & Rad HealthAnimal Drugs & FeedsFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 36 inspections across 32 sites are on record.
  • 50 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-03-27.

At a glance

Inspections

36

Sites

32

Observations

50

Career since

Jul 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Eurofins Infinity Laboratory Group, LLC27 Mar 2026Human Drugs
Virbac Corporation22 Jan 2026Animal Drugs & FeedsOn file
Eurofins EAG Materials Science, LLC11 Dec 2025Human DrugsOn file
SpecGx LLC22 Oct 2025Human DrugsOn file
Buckeye International Inc21 Aug 2025Human DrugsOn file

Sites inspected

Eurofins Infinity Laboratory Group, LLCSaint Louis, United States1 insp.
Virbac CorporationBridgeton, United States1 insp.
Eurofins EAG Materials Science, LLCMaryland Heights, United States1 insp.
SpecGx LLCSaint Louis, United States1 insp.
Buckeye International IncMaryland Heights, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Robert J Ham6 shared
Gretchen L Trendel3 shared
Scott D Mcgrew2 shared

Full investigator report

Get the verbatim findings behind Mary L Schuckmann's 50 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site